Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 1 recruiting now small index

Muscle Invasive Bladder Cancer (MIBC) clinical trials

1 of 1 indexed Muscle Invasive Bladder Cancer (MIBC) trials are currently recruiting.

Corpus placement: #11,370 of 28,707 conditions by registered trial count.

1 US clinical trials · 1 currently recruiting · #11,370 of 28,707 conditions by registered trial count

Muscle Invasive Bladder Cancer (MIBC): 1 US clinical trial tracked, 1 recruiting.

Muscle Invasive Bladder Cancer (MIBC) is the subject of 1 registered US clinical trials on ClinicalTrials.gov, 1 of them currently open to new participants. The most active sponsor is Johns Hopkins University, running 1 of these trials.

Enrollment posture brief

Registry condition muscle-invasive-bladder-cancer-mibc

OPEN 1 | RECR 100% | LATE 0 | EARLY 0 | RANK #11370 | SPON 1

Nearest open-share peer: Aortic Arch Aneurysm (100% recruiting · 5 trials)

Muscle Invasive Bladder (th…100%Ablation80%ACL Reconstruction80%Abuse, Drug60%Acceptability60%
Open-enrollment share among volume-matched conditions near Muscle Invasive Bladder Cancer (MIBC)

Muscle Invasive Bladder Cancer (MIBC) lists 1 open slots (100% of 1 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Muscle Invasive Bladder Cancer (MIBC) on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Muscle Invasive Bladder Cancer (MIBC) is recruiting above its size-band peers.

    1 of 1 indexed trials (100%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

Phase Distribution

Phase data not available

Top Sponsors

Named interventions

Most-linked intervention names on Muscle Invasive Bladder Cancer (MIBC) records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

ERAS Other
1 trials
Intravenous fluids Other
1 trials

US sites by state

Facility locations filed on Muscle Invasive Bladder Cancer (MIBC) trials. A trial with sites in several states counts in each.

Maryland 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Muscle Invasive Bladder Cancer (MIBC) page

1 registered trials, 1 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

  • 1 Muscle Invasive Bladder Cancer (MIBC) trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
  • Johns Hopkins University sponsors the most Muscle Invasive Bladder Cancer (MIBC) trials on record, review their full trial history before evaluating a specific study. See Johns Hopkins University's trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Muscle Invasive Bladder Cancer (MIBC) condition card totals 1 registered trials; most-linked intervention ERAS; top US site state Maryland. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.